채용
岗位职责:
- 参加GMP培训并遵循GMP规则在车间内完成生产任务;
- 负责主导和保证上游生产各工序按照公司要求开展生产工作;
- 负责组织生产上游部门GMP相关文件的撰写、升版和审核工作;
- 负责解决技 术转移、工艺放大及日常生产中遇到的技术问题,改进并优化生产流程及工作方法,定期进行总结和汇报;
- 负责板块内生产人员的技术、设备、规范、工艺等相关文件的培训与考核;
- 负责组织和协调变更的发起和组织风险评估以及方案制定等工作;
- 负责上游生产中出现的偏差、偏离、异常事件的调查和组织工作(偏差、变更、CAPA等);
- 参与NMPA、FDA等审计部门或合作单位审计,并根据审计整改项执行整改及反馈;
- 与研发部门、供应链部门、工程部门、QA部门、QC部门等相互合作,推进生产的顺利进行。
任职要求:
- 本科及以上学历;微生物、生物化学、生物制药和发酵工程等专业优先;
- 有8-10年及以上相关生物制药行业GMP工作经验者优先考虑;
- 熟悉上游生产设备的操作原理、维护、管理;
- 熟悉生物药GMP厂房的运行和管理;
- 具备细胞培养板块人员招聘、培训、带队伍、现场管理等职能;
- 具备控制所管理板块预算和成本,实现投入和产出合理化。;
- 具有良好的沟通表达能力;
- 熟悉生物制药领域GMP的相关法规要求;
- 熟悉偏差发起、调查、关闭和CAPA执行的整个质量管控过程;
- 具备一定的英文阅读和书写能力,能够撰写、审阅GMP相关文件;
- 具有吃苦耐劳的品质和良好的身体素质,与积极向上持续学习的能力;
- 熟练使用Office、Visio等办公软件。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고
BioNTech 소개

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago



